Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TDP-43 Epigenetic Facets and Their Neurodegenerative Implications. | Int J Mol Sci | 2023 | 37762112 | PubTator, text mining | PubMed |
| Hypoxic regulation of hypoxia inducible factor 1 alpha via antisense transcription. | J Biol Chem | 2023 | 37748649 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer. | J Transl Med | 2023 | 37735483 | PubTator, text mining | PubMed |
| Transcriptional linkage analysis with in vivo AAV-Perturb-seq. | Nature | 2023 | 37730998 | PubTator, text mining | PubMed |
| The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance. | J Transl Med | 2023 | 37726835 | PubTator, text mining | PubMed |
| Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models. | J Clin Invest | 2023 | 37725435 | PubTator, text mining | PubMed |
| Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma. | Cell Rep | 2023 | 37708024 | PubTator, text mining | PubMed |
| Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race-specific luminal-basal and microenvironmental differences. | Cancer Commun (Lond) | 2023 | 37700560 | PubTator, text mining | PubMed |
| Nucleosome repositioning in chronic lymphocytic leukemia. | Genome Res | 2023 | 37699659 | PubTator, text mining | PubMed |
| Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. | Cancer Discov | 2023 | 37694973 | PubTator, text mining | PubMed |
| The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistance. | Cell Biosci | 2023 | 37691108 | PubTator, text mining | PubMed |
| CHD7 variants associated with hearing loss and enlargement of the vestibular aqueduct. | Hum Genet | 2023 | 37668839 | PubTator, text mining | PubMed |
| Novobiocin blocks nucleic acid binding to Polθ and inhibits stimulation of its ATPase activity. | Nucleic Acids Res | 2023 | 37665033 | PubTator, text mining | PubMed |
| New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics. | Front Oncol | 2023 | 37664036 | PubTator, text mining | PubMed |
| Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. | Cancer Res Commun | 2023 | 37663929 | PubTator, text mining | PubMed |
Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. | J Transl Med | 2023 | 37660060 | PubTator, text mining | PubMed |
| Cell-cell interactions during the formation of primordial follicles in humans. | Life Sci Alliance | 2023 | 37643865 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 37627214 | PubTator, text mining | PubMed |
| The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review. | Biomedicines | 2023 | 37626776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=8